Cafepharma Today

AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Novartis posts better-than-expected fourth-quarter sales
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Forbes
Wednesday, January 21, 2009 - 9:14am
tags:
Bloomberg
Wednesday, January 21, 2009 - 9:12am
Investopedia
Tuesday, January 20, 2009 - 7:59pm
tags:
TheStreet.com
Tuesday, January 20, 2009 - 4:02pm
New York Times, NY
Tuesday, January 20, 2009 - 3:32pm
Hays Pharma, UK
Tuesday, January 20, 2009 - 3:30pm
WSJ Online
Tuesday, January 20, 2009 - 3:28pm
Seeking Alpha
Tuesday, January 20, 2009 - 3:27pm
Fierce Biotech
Tuesday, January 20, 2009 - 11:48am
Fierce Pharma
Tuesday, January 20, 2009 - 11:46am
TheStreet.com
Tuesday, January 20, 2009 - 11:40am
tags:
Yahoo/AP
Tuesday, January 20, 2009 - 11:37am
tags:
Bizjournals.com
Tuesday, January 20, 2009 - 11:36am
WSJ Online
Tuesday, January 20, 2009 - 11:35am
InVivo
Tuesday, January 20, 2009 - 10:17am
Fierce Pharma
Tuesday, January 20, 2009 - 10:15am

Pages

Latest Jobs

Houston, Texas, 77002
Inizio Engage
Fort Worth, Texas, 76102
Inizio Engage
Charlotte, North Carolina, 28245
Inizio Engage
Newark, New Jersey, 07175
Inizio Engage
Little Rock, Arkansas, 72208
Inizio Engage
Philadelphia, Pennsylvania, 19107
Inizio Engage
Las Vegas, Nevada, 89105
Professional Case Management
Atlanta, Georgia, 30383
Inizio Engage
Annapolis, Maryland, 21401
Jazz Pharmaceuticals

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.